Tandem Diabetes Care TNDM
NASDAQ TNDM
$18.31 -0.80 (-4.19%)
As of: Sep 10, 2026 · 3:59 PM EDT

Tandem Diabetes Care (TNDM) Assets Average (2014 - 2026)

Tandem Diabetes Care's (TNDM) quarterly Assets Average came in at $1.2 billion in Q2 2026, up 28.35% on a YoY basis from $898.9 million in Q2 2025, and up 13.42% quarter-over-quarter from $1.0 billion in Q1 2026.

Analysis

Tandem Diabetes Care (TNDM) Assets Average (2014 - 2026) Analysis & Trends

Tandem Diabetes Care (TNDM) has reported Assets Average for 13 consecutive years, with $1.2 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Assets Average rose 28.35% year-over-year to $1.2 billion; the trailing twelve-month figure through Jun 2026 stood at $1.2 billion (up 28.35% YoY), and the FY2025 full-year result was $924.4 million, down 3.73% from the prior year.
  • Assets Average climbed to $1.2 billion in Q2 2026 per TNDM's latest filing, from $1.0 billion in the prior quarter.
  • Across five years, Assets Average topped out at $1.2 billion in Q2 2026 and bottomed at $875.2 million in Q3 2025.
  • Historically, Assets Average has averaged $971.5 million across 5 years, with a median of $949.0 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Assets Average surged 32.42% in 2022, then slipped 9.89% in 2023.
  • Over 5 years, Assets Average stood at $1.1 billion in 2022, then fell by 9.89% to $946.3 million in 2023, then increased by 1.73% to $962.7 million in 2024, then decreased by 8.81% to $877.9 million in 2025, then surged by 31.43% to $1.2 billion in 2026.
  • According to Business Quant data, Assets Average over the past three periods registered $1.2 billion, $1.0 billion, and $877.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Abbott Laboratories 179.79 Bn 174.18 Bn 7.27 Bn 109.82 Bn
2 Intuitive Surgical 127.69 Bn 122.47 Bn 1.96 Bn 20.49 Bn
3 Medtronic 117.23 Bn 108.41 Bn 6.34 Bn 93.17 Bn
4 Stryker 103.55 Bn 100.07 Bn 4.50 Bn 47.11 Bn
5 Boston Scientific 63.24 Bn 62.70 Bn 3.85 Bn 44.78 Bn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 13.59 Bn
7 Alcon 32.83 Bn 31.37 Bn 1.68 Bn 31.36 Bn
8 Dexcom 32.30 Bn 30.35 Bn 830.00 Mn 6.54 Bn
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 10.74 Bn
10 Tandem Diabetes Care 1.26 Bn 804.14 Mn 144.78 Mn 1.15 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.15 Bn
Mar 31, 2026 1.02 Bn
Dec 31, 2025 877.88 Mn
Sep 30, 2025 875.19 Mn
Jun 30, 2025 898.94 Mn
Mar 31, 2025 944.90 Mn
Dec 31, 2024 962.69 Mn
Sep 30, 2024 947.62 Mn
Jun 30, 2024 939.27 Mn
Mar 31, 2024 946.85 Mn
Dec 31, 2023 946.28 Mn
Sep 30, 2023 943.29 Mn
Jun 30, 2023 950.41 Mn
Mar 31, 2023 1.00 Bn
Dec 31, 2022 1.05 Bn
Sep 30, 2022 1.04 Bn
Jun 30, 2022 1.03 Bn
Mar 31, 2022 960.21 Mn
Dec 31, 2021 877.71 Mn
Sep 30, 2021 822.76 Mn